EP 4203987 A2 20230705 - COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR NEUROINFLAMMATION
Title (en)
COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR NEUROINFLAMMATION
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON NERVENENTZÜNDUNGEN DES AUGES
Title (fr)
COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT DE LA NEURO-INFLAMMATION OCULAIRE
Publication
Application
Priority
- US 202063070145 P 20200825
- US 2021047569 W 20210825
Abstract (en)
[origin: WO2022046919A2] Provided herein are products of manufacture, kits, and methods, for: treating, ameliorating, protecting against, reversing or decreasing the severity or duration of neuroinflammation in the eye, as for example, during glaucomatous neurodegeneration by administration of a polypeptide composition or a nucleic acid composition encoding a polypeptide composition, wherein the polypeptide composition is, or is comprised of, an ApoA-I Binding Protein.
IPC 8 full level
A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61P 3/06 (2006.01); A61P 29/00 (2006.01)
CPC (source: EP)
A61K 9/0048 (2013.01); A61K 38/1709 (2013.01); A61P 3/06 (2018.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); A01K 2217/075 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0306 (2013.01); A01K 2267/0368 (2013.01); A61K 48/005 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022046919 A2 20220303; WO 2022046919 A3 20220414; CA 3190597 A1 20220303; EP 4203987 A2 20230705; EP 4203987 A4 20241016
DOCDB simple family (application)
US 2021047569 W 20210825; CA 3190597 A 20210825; EP 21862665 A 20210825